Skip to content

Patients' experiences with neuraltherapy during an inpatient stay at the Clinic of Complementary and Integrative Medicine - a qualitative study with semistructured interviews

Patients' experiences with neuraltherapy during an inpatient stay at the Clinic of Complementary and Integrative Medicine - a qualitative study with semistructured interviews - STAT-NT-Quali-I

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00004567
Enrollment
30
Registered
2012-11-27
Start date
2012-11-26
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diseases for which neuraltherapy is indicated

Interventions

Group 1: Patients treated with neuraltherapy during their inpatient stay are asked if they are willing to participate in the interview study. The appointment for the semistructured in-depth interviews

Sponsors

Universität Duisburg-Essen Lehrstuhl und Klinik für Naturheilkund und Integrative Medizin, Knappschafts-Krankenhaus, Kliniken Essen-Mitte
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - treatment with neuraltherapy during their inpatient stay at the Clinic for Complementary and Integrative Medicine, Essen, Germany - signed informed consent - sufficient knowledge of the German language - minimum age of 18

Exclusion criteria

Exclusion criteria: /

Design outcomes

Primary

MeasureTime frame
Patients' experiences with neuraltherapy: onetime, semistructured, in depth interviews

Secondary

MeasureTime frame
side effects

Countries

Germany

Contacts

Public ContactKyung-Eun Choi

Universität Duisburg-Essen, Lehrstuhl und Klinik für Naturheilkunde und Integrative Medizin, Knappschafts-Krankenhaus, Kliniken Essen-Mitte

k.choi@kliniken-essen-mitte.de0049-(0)201 174 25055

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 4, 2026